Breakthrough science, one person at a time
Spark Therapeutics (sparktx.com) scores 74 out of 100 on Brand Analyzer, placing it in the Brand-Ready tier among Healthcare brands, in the 37th percentile of 12024 Healthcare brands.
Spark Therapeutics is a gene therapy company headquartered in Philadelphia, founded in 2013 and now part of Hoffmann-La Roche (Genentech). The company focuses on developing treatments for genetic diseases that were previously untreatable, combining scientific research with patient-centered care. Its work targets patients, caregivers, and healthcare providers seeking advanced gene therapy options. Spark Therapeutics operates within the broader healthcare and biotechnology sector.
| Brand Name | Spark Therapeutics |
|---|---|
| Domain | sparktx.com |
| Industry | Healthcare |
| Founded | 2013 |
| Headquarters | Philadelphia |
| Parent Company / Owner | Hoffmann-La Roche |
| Main Competitors | Sarepta Therapeutics (83/100), bluebird bio (57/100), uniQure (81/100), REGENXBIO (74/100), BioMarin Pharmaceutical (84/100), Novartis Gene Therapies (71/100) |
Moz Domain Authority 51/100 vs category average 41 / leader 95 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "Breakthrough science. One moment, one day, one person at a time." (Meta description: 11 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: og:title, og:description, og:image, Twitter cards, canonical. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: No robots.txt found (default: all bots allowed, but explicit file preferred) - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Cloudflare.
Social footprint: verified profiles on GitHub; no detected presence on Facebook, X (Twitter), LinkedIn, Instagram, YouTube - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked October 2026.
When asked "What is Spark Therapeutics?", Claude could identify the brand as of October 2026. Spark Therapeutics is a gene therapy company based in Philadelphia, now part of Roche, known for developing treatments for genetic diseases, especially inherited retinal disorders. Best known for Developing Luxturna, the first FDA-approved gene therapy for an inherited retinal disease causing blindness.
When asked "Best brands similar to Spark Therapeutics?", Claude would recommend Spark Therapeutics as of October 2026. It's a pioneering name in gene therapy and would naturally come up when discussing leaders in that space, especially for rare genetic and eye diseases.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Spark Therapeutics's main competitors in Healthcare: Sarepta Therapeutics (83/100), bluebird bio (57/100), uniQure (81/100), REGENXBIO (74/100), BioMarin Pharmaceutical (84/100).
Sources: Brand Analyzer scan
Spark Therapeutics has limited AI-search visibility, scoring 32/100 on Brand Analyzer's AI visibility composite (visibility 23, trust 29, recommendation 53). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Spark Therapeutics official site
Spark Therapeutics was founded in 2013. Spark Therapeutics operates in the Healthcare category. It is analyzed by Brand Analyzer across seven brand dimensions and AI-search visibility.
Sources: Wikidata
Spark Therapeutics is headquartered in Philadelphia. Spark Therapeutics operates in the Healthcare category.
Sources: Wikidata
Spark Therapeutics scores 53/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: Spark Therapeutics official site
Spark Therapeutics is a gene therapy company based in Philadelphia, founded in 2013, that is now part of Hoffmann-La Roche (operating under Genentech). It focuses on developing treatments for genetic diseases.
Sources: Spark Therapeutics official site
Spark Therapeutics can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Spark Therapeutics official site
Spark Therapeutics is owned by or part of Hoffmann-La Roche. Spark Therapeutics operates in the Healthcare category.
Sources: Wikidata
Spark Therapeutics develops gene therapy treatments aimed at addressing previously untreatable genetic diseases. The company combines scientific research with a patient-focused approach to improve outcomes for individuals affected by these conditions.
Sources: Spark Therapeutics official site
Spark Therapeutics scores 32/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Spark Therapeutics has a weak AI-visibility profile at 32/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (53/100) and its weakest is visibility (23/100). It benefits from a Wikidata knowledge-graph entry, a Moz Domain Authority of 51/100 and open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, thin schema.org structured data and no llms.txt to steer AI to its best pages. In a live check, Claude could already identify Spark Therapeutics from memory (October 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to Spark Therapeutics: Space Cabin (74/100), Sonida Senior Living (74/100), Speedback (74/100), SRFax (74/100).
A step up - brands to learn from: Zymo Research (81/100), Zurich Insurance Group (81/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.